HOME >> MEDICINE >> NEWS
Statement on the findings of the Women's Health Study

The Women's Health Study is the first large clinical trial to study the use of low-dose aspirin to prevent heart attack and stroke in women. The 10-year randomized, double-blind, placebo-controlled study was conducted among nearly 40,000 healthy women age 45 and older. Although studies have shown that low-dose aspirin reduces the risk of a first heart attack in men, there have been few such studies in women. The study was supported by the National Institutes of Health's National Heart, Lung, and Blood Institute and the National Cancer Institute.

The Women's Health Study found that aspirin did not prevent first heart attacks or death from cardiovascular causes in women. Low-dose aspirin (100 mg on alternate days) lowered the incidence of a first major cardiovascular event (nonfatal heart attack, non-fatal stroke, or death from cardiovascular causes) by 9 percent. This was not statistically significant. Stroke was 17 percent lower in the aspirin group, a statistically significant difference. The findings of the study will be presented at the American College of Cardiology's (ACC) annual meeting in Orlando, FL and also published online in The New England Journal of Medicine March 7, 2005 and in print in the March 31 issue.

The greatest benefit appeared to be in women 65 and older. In this sub-group, low-dose aspirin reduced the risk of major cardiovascular events by 26 percent. However, the benefits of low-dose aspirin therapy must be weighed against the risk of an increased chance of internal bleeding, a well-known side effect of aspirin use.

The bottom line is that many women, especially those 65 and older, may benefit from taking low-dose aspirin every other day to prevent stroke. But it is important for women to weigh the risk and benefits of taking aspirin and to consult with their doctor.

Above all, women, like men, should adopt the well-proven approaches that reduce the risk of heart disease eating for heart health,
'"/>

Contact: NHBLI Communications Office
nhlbi_news@nhlbi.nih.gov
301 496-4236
NIH/National Heart, Lung, and Blood Institute
7-Mar-2005


Page: 1 2

Related medicine news :

1. Statement: Implantable medical identification chip
2. Statement from Barbara Alving of NHLBI on guidelines for cardiovascular disease prevention in women
3. Statement from Spondylitis Association of America
4. Statement by Dr. Colwell on Nobel Prizes in Science and NSF onnection
5. The CARDIA Study: Statement from Dr. Claude Lenfant, director, National Heart, Lung, and Blood Institute
6. Statement from Dr. Claude Lenfant, director, NHLBI and Dr. Phillip Gorden, director, NIDDK
7. Statement from Claude Lenfant, M.D., NHLBI Director, on Trends in Hypertension
8. Dental Researchers Retract Statement Indicating Hydrogen Peroxide May Be Cancer Promoter
9. Latest findings on genetic blood disorder Cooleys Anemia
10. Hard choices: Pitt researcher presents findings on when to accept organ transplants
11. Contrary to previous findings, smoking is detrimental to patients with Alzheimers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... Calif. (PRWEB) , ... August 05, 2020 , ... ... America’s healthcare system has repeatedly risen to unprecedented challenges. Regardless of the obstacle ... such as personal protective equipment (PPE) and the cancellation or postponement of all ...
(Date:8/5/2020)... ... 2020 , ... The Veterinary Cooperative named Ginni Hamele, an ... purchasing Cooperative in the United States. , Hamele has spent the last nine ... and experience in the animal health industry. In her most recent position for ...
(Date:8/5/2020)... ... 2020 , ... Total Spectrum, a company of behavioral clinicians ... is delighted to announce the grand opening of their new ABA learning ... Spectrum now proudly serves ten different locations across the Midwest. The staff of ...
(Date:8/3/2020)... N.J. (PRWEB) , ... August 03, 2020 , ... ... in Florida will launch its Suite360:Mental Health and Prevention program district-wide, developed to ... and Child Trafficking Prevention. , Florida schools and districts must provide their ...
(Date:8/3/2020)... ... August 03, 2020 , ... ... the first patients with first-line advanced pancreatic cancer in a phase 2 study ... of 9-ING-41, (NCT03678883, EudraCT#:2018-003739-32). 9-ING-41 is Actuate’s proprietary small molecule glycogen synthase ...
Breaking Medicine News(10 mins):
(Date:8/5/2020)... Ohio (PRWEB) , ... August 04, 2020 , ... ... loved ones, has announced the Best Rehab Facilities in Akron, Ohio for 2020. The ... accompanying services and more. , According to recent studies , drug overdose ...
(Date:8/5/2020)... ... ... Fifty six percent of older adults think we need to invest more in Medicare ... according to a new survey by The Senior Citizens League (TSCL). “Boosting funding ... says Mary Johnson, a Medicare, and Social Security policy analyst for The Senior Citizens ...
(Date:8/5/2020)... Va. (PRWEB) , ... August ... ... Cleaning and Disinfectant Programs: , Best Practices During COVID-19, An FDAnews Webinar, ... The task of maintaining a controlled cleanroom is never simple and COVID-19 ...
Breaking Medicine Technology:
Cached News: